<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on US Bioscience Incorporated from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated US Bioscience Incorporated news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 14:16:53 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=US+Bioscience+Incorporated" rel="self" type="application/rss+xml" />

	
<item><title>Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042328&amp;HITNO=0&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042328&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539386355%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042328&amp;HITNO=0&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042328&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539386355%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>RBC Dain Rauscher:</description></item>
<item><title>Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042326&amp;HITNO=1&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042326&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539386015%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042326&amp;HITNO=1&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042326&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539386015%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire via Yahoo!:</description></item>
<item><title>Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042273&amp;HITNO=2&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042273&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539369382%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042273&amp;HITNO=2&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042273&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539369382%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042214&amp;HITNO=3&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042214&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539361221%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042214&amp;HITNO=3&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042214&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539361221%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire:</description></item>
<item><title>Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042212&amp;HITNO=4&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042212&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539361205%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042212&amp;HITNO=4&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042212&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539361205%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire UK:</description></item>
<item><title>Anthem Blue Cross raises premium by 39%: HHS Secretary calls for detailed public justification</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034392&amp;HITNO=5&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034392&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535763571%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034392&amp;HITNO=5&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034392&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535763571%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Genta commences Phase 2 trial of tesetaxel on first subject</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034650&amp;HITNO=6&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034650&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535909558%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034650&amp;HITNO=6&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034650&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535909558%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033752&amp;HITNO=7&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033752&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535381947%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033752&amp;HITNO=7&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033752&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535381947%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>TickerTech.com:</description></item>
<item><title>Genta commences treatment in tesetaxel Phase 2 trial for advanced melanoma</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033220&amp;HITNO=8&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033220&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535076243%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033220&amp;HITNO=8&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033220&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535076243%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>PuraMed BioScience Secures up to $7.5 Million Funding Commitment From Southridge Partners II, Ltd.</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036167&amp;HITNO=9&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036167&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536517985%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036167&amp;HITNO=9&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036167&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536517985%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXBusiness.com:</description></item>
<item><title>PuraMed BioScience Secures up to $7.5 Million Funding Commitment From Southridge Partners II, Ltd</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035190&amp;HITNO=10&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035190&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536153500%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035190&amp;HITNO=10&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035190&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536153500%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GlobeNewswire via Yahoo!:</description></item>
<item><title>PuraMed BioScience Secures up to $7.5 Million Funding Commitment</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035160&amp;HITNO=11&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035160&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536143566%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035160&amp;HITNO=11&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035160&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536143566%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GlobeNewswire via MSN Money:</description></item>
<item><title>Dementia Rates Escalate as Brain Capacity Diminishes with Age</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034602&amp;HITNO=12&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034602&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535876914%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034602&amp;HITNO=12&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034602&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535876914%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>3SBio Gains China Rights to Another Dialysis Drug</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033820&amp;HITNO=13&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033820&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535413965%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033820&amp;HITNO=13&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033820&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535413965%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Seeking Alpha:</description></item>
<item><title>PuraMed enters credit equity deal worth $7.5M</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036115&amp;HITNO=14&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036115&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536500670%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036115&amp;HITNO=14&amp;MSIZE=903&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=US%20Bioscience%20Incorporated&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036115&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536500670%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Journal of Jacksonville:</description></item>
</channel></rss>